Drug intelligence / Profile preview

LAMP3 small interfering RNA

Development stage
Preclinical
Lead developer
National Institute of Allergy and Infectious Diseases
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Local
01

Overview

LAMP3 small interfering RNA (siRNA) is an experimental RNA interference (RNAi) agent designed to silence the expression of the *LAMP3* (Lysosome-associated membrane glycoprotein 3) gene. In the context of cervical cancer research, LAMP3 has been identified as a key driver of an antiviral gene sub-network, often upregulated due to chromosomal gains on the 3q region. By targeting LAMP3 mRNA for degradation, this siRNA reduces the expression of interferon-dependent genes such as STAT1, IRF7, and OAS1. Research indicates that LAMP3 overexpression is associated with increased metastatic potential and the elimination of episomal human papillomavirus (HPV), which may paradoxically aid tumor progression by releasing the expression of viral oncogenes E6 and E7. The siRNA is primarily used as a research tool to investigate the molecular mechanisms of cervical carcinogenesis and the host immune response to viral infection.

Other names
LAMP3 siRNALAMP-3 siRNALAMP 3 siRNAsiRNA targeting LAMP3Lysosome-associated membrane glycoprotein 3 siRNA
02

Targets

CD63 (Lysosome-associated membrane glycoprotein 3)

Beyond the preview

Go deeper on LAMP3 small interfering RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAMP3 small interfering RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call